Literature DB >> 19138468

Omental therapy for primary progressive aphasia with tau negative histopathology: 3 year study.

William R Shankle1, Junko Hara, Lynda Bjornsen, George F Gade, Peter C Leport, Mir B Ali, Jinho Kim, Maryellen Raimo, Linda Reyes, Terence O'Heany, Ismael Mena.   

Abstract

OBJECTIVE: Omentum transposition surgery (OT) applied to various neurodegenerative disorders has produced clinically significant improvement, which may be due to omentally-derived factors. To evaluate the clinical effect of left hemisphere OT in a primary progressive aphasia (PPA) patient, 3 year follow-up data were analysed.
METHODS: Left hemisphere OT was performed on a 68-year-old male with PPA, characterized by moderate dementia and severe expressive aphasia with relatively preserved comprehension, object recognition and visual-spatial abilities. He was longitudinally assessed with cognitive, functional, behavioral and brain HMPAO SPECT measures pre-OT, at baseline and every 3-6 months for 34 months.
RESULTS: All measures improved above baseline for >20 months and persisted at or above baseline for 34 months. Cortical activity increased by a maximum of 21% underneath transposed omentum and in synaptically connected areas, and persisted in >50% of the cortex for at least 12 months. Subjectively, family members observed improved verbal and non-verbal communication.
CONCLUSION: OT produced a sustained, beneficial treatment effect in PPA and warrants further clinical and basic research to identify explanatory factors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19138468     DOI: 10.1179/174313209X382511

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  3 in total

1.  Treatment of Primary Progressive Aphasia.

Authors:  Donna C Tippett; Argye E Hillis; Kyrana Tsapkini
Journal:  Curr Treat Options Neurol       Date:  2015-08       Impact factor: 3.598

2.  Binswanger disease may benefit from omental arteries.

Authors:  Harry S Goldsmith
Journal:  Surg Neurol Int       Date:  2015-01-07

3.  Alzheimer's disease can be treated: Why the delay?

Authors:  Harry S Goldsmith
Journal:  Surg Neurol Int       Date:  2017-07-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.